CTXR Citius Pharmaceuticals
Citius Pharmaceuticals earnings company data as of 7:18 PM ET 8/21
- 1 of 1 EPS beats
History
1 period, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 14 Aug | EPS | -0.36 | -0.34 | Beat |
| Rev | — | $1.5M | — |
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 3.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | QUARTERLY REPORT | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| SCHEDULE 13D/A | — | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 10-Q | QUARTERLY REPORT | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 8-K | 1.01,9.01 | Filing Doc | |
| 8-K | 3.02,8.01,9.01 | Filing Doc | |
| 424B5 | PROSPECTUS SUPPLEMENT | Filing Doc | |
| 8-K | 1.01,8.01,9.01 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| DEF 14A | DEFINITIVE PROXY STATEMENT | Filing Doc | |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | QUARTERLY REPORT | Filing Doc | |
| 8-K | 2.02,3.01,9.01 | Filing Doc | |
| 10-K/A | AMENDMENT NO. 1 TO FORM 10-K | Filing Doc | |
| 10-K | ANNUAL REPORT | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.